Pharmaceutical drug

Pharmacy professionals are familiar with existing pharmacy dispensing processes. In general, patients provide pharmacy professionals with their prescription(s). Pharmacy professionals obtain patients’ insurance and demographic information and submit pharmacy claims to the Pharmacy Benefits Manager (PBM). In a matter of minutes, pharmacy professionals can determine coverage, patients’ copayment and their reimbursement. Once patient counseling occurs, patients pay the appropriate copayment and the…

In society today, pharmacy is an interesting field that is rapidly advancing. A “Pharm-D” degree grants access to numerous possibilities in the pharmaceutical field. I am certain that obtaining a doctorate of pharmacy will reveal many opportunities for me in the future. Yet, I believe that one must have clear goals, determination and motivation to successfully achieve a career in pharmacy. My personal interest in pharmacy began when I was in high school, specifically when I spoke to a…

Consumers of pharmaceuticals are affected by a number of factors that can alter and dictated their cost. The EpiPen increased its price by about $500 from the year 2007 to 2016, without the price being influenced by shortages or inflation (Babcock). The change that occurred…

Drug Pushing: a Prescription Proposal from a Pharmaceutical Valencia Cave, Holly Costanzo, Sean McCart, Josh Mosholder Towson University Michael Kim is a pediatrician at a practice outside of Baltimore. Walking into his office one day, he sees a brand new golf clubs set against his desk. He remembered getting an email earlier that week from Apativ, a large pharmaceutical company. It was about a new drug, Paxaflora, which helps children with congestive heart failure. If given the drug, it would…

1.1. Background: It is well known that pharmaceutical companies offer various gifts and incentives to physicians to prescribe their drugs. What are the advantages and positive aspects of this collaboration? And what are the negative aspects? Are the doctors really influenced? Does this influence affect prescribing proper drugs for patients? Can this interaction lead to a biased decision for therapy? In which limit are these interactions ethically and lawfully approved? Is receiving incentives…

For patients with high cholesterol, Praluent, also known by its generic name, alirocumab, is the new FDA approved drug that is effective at improving liver function to lower bad cholesterol (Goldschmidt). Unlike other available medication in the market, Praluent is a completely new class of drug that enhance the lives of many individuals and provides an alternative method for treating cholesterol that will appeal to patients who do not see results from their current medication or experience…

discusses Moleculin’s Annamycin in the wake of Celator’s recent success with a similar drug and Minerva’s phase 2b data for schizophrenia drug MIN-101. Based on your votes for the more interesting topic, Slingshot Insights will sponsor the expert’s cost and you can join! Option 1: Discussing Moleculin’s Annamycin after the company’s recent IPO, promising Phase 1, and Celator’s successful phase 3 trials for similar drug VYXEOS. What differentiates Annamycin, what does Celator’s success mean for…

Soaring price of generic drugs: Depriving consumers from better healthcare Generic drugs prices are rising exponentially with every passing year. Generic drugs are regarded as a boon to mankind not only because they are comparable to their brand counterparts in terms of quality, safety and efficacy but also because they are affordable by all the people irrespective of their financial class. A survey revealed that generic drugs have saved US patient’s 1.3 trillion dollar in past decade. But with…

The pharmaceutical industry can normally be seen as a positive thing because of the goods they produce. They yield medication aiding individuals escape the sick role, and fulfill their social roles. However, the way they operate does not stem for the good of the people, but rather to gain profit. To begin with, pharmaceutical companies are incapable of operating without medical experts like doctors, nurse practitioner, and so forth, because they hold the power to prescribe drugs (Oldani, 2004,…

prices for existing branded prescription drugs accounted for $20 billion of the industry’s 2013 sales growth before discounts and rebates.” (http://www.businessweek.com/articles/2014-05-08/why-prescription-drug-prices-keep-rising-higher) Rising prescription drug prices have been a significant aspect of the larger healthcare discussion. An analysis of prescription drug development, marketing, and consumer pricing by the largest contributing pharmaceutical companies reveal substantive challenges…